The American College of Gastroenterology has published its first clinical guideline on the diagnosis and management of ...
Helicobacter pylori, a common bacterium known as H. pylori, now ranks as one of the leading infectious causes of cancer worldwide, responsible for an estimated 810,000 cancer cases annually.
6d
HealthDay on MSNLower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERDFor patients with gastroesophageal reflux disease (GERD), those with Helicobacter pylori infection have significantly lower ...
Excessive sodium intake has been identified as a significant risk factor in the development of gastric cancer. This mineral, ...
The purpose of this review is to summarize the role of the phenotypes, virulence-related genes and genotypes of H. pylori in the establishment of gastric colonization and the development of ...
These findings are suggestive but not diagnostic of H. pylori infection. Magnifying endoscopy can reveal more precisely the abnormal mucosal patterns in an H. pylori-infected stomach; however ...
A pioneering study has revealed new insights into the role of gastric bacteria in stomach cancer development that could pave the way for a more effective treatment of pre-cancer.
The study led by researchers from the University of Birmingham identified a crucial interaction between Helicobacter pylori and non-H. pylori bacteria in the pre-cancerous stage of gastric cancer. The ...
The Alnwick business is poised to draw up a clinical trial for HELIX, the firm's first product being brought to market ...
pylori eradication on the rebound of reflux-related symptoms. Patients who were positive for H. pylori were randomly assigned to receive bacterial eradication with triple therapy for 2 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results